Sangam (India) Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 18, 2025, 6:31 pm

Competitors of Sangam (India) Ltd

All Competitor Stocks of Sangam (India) Ltd

Quarterly Result

Last Updated: August 20, 2025, 4:10 am

Below is a detailed analysis of the quarterly data for Sangam (India) Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 789.77 Cr.. The value appears strong and on an upward trend. It has increased from 734.30 Cr. (Mar 2025) to 789.77 Cr., marking an increase of 55.47 Cr..
• For Expenses, as of Jun 2025, the value is 732.14 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 676.60 Cr. (Mar 2025) to 732.14 Cr., marking an increase of 55.54 Cr..
• For Operating Profit, as of Jun 2025, the value is 57.63 Cr.. The value appears to be declining and may need further review. It has decreased from 57.70 Cr. (Mar 2025) to 57.63 Cr., marking a decrease of 0.07 Cr..
• For OPM %, as of Jun 2025, the value is 7.30%. The value appears to be declining and may need further review. It has decreased from 7.86% (Mar 2025) to 7.30%, marking a decrease of 0.56%.
• For Other Income, as of Jun 2025, the value is 11.08 Cr.. The value appears strong and on an upward trend. It has increased from 10.42 Cr. (Mar 2025) to 11.08 Cr., marking an increase of 0.66 Cr..
• For Interest, as of Jun 2025, the value is 30.30 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 25.47 Cr. (Mar 2025) to 30.30 Cr., marking an increase of 4.83 Cr..
• For Depreciation, as of Jun 2025, the value is 35.88 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 29.85 Cr. (Mar 2025) to 35.88 Cr., marking an increase of 6.03 Cr..
• For Profit before tax, as of Jun 2025, the value is 2.53 Cr.. The value appears to be declining and may need further review. It has decreased from 12.80 Cr. (Mar 2025) to 2.53 Cr., marking a decrease of 10.27 Cr..
• For Tax %, as of Jun 2025, the value is 15.81%. The value appears to be improving (decreasing) as expected. It has decreased from 25.62% (Mar 2025) to 15.81%, marking a decrease of 9.81%.
• For Net Profit, as of Jun 2025, the value is 2.13 Cr.. The value appears to be declining and may need further review. It has decreased from 9.52 Cr. (Mar 2025) to 2.13 Cr., marking a decrease of 7.39 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.47. The value appears to be declining and may need further review. It has decreased from 2.11 (Mar 2025) to 0.47, marking a decrease of 1.64.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:31 am

Growth

Last Updated: September 5, 2025, 1:20 pm

Balance Sheet

Last Updated: September 10, 2025, 2:25 pm

Below is a detailed analysis of the balance sheet data for Sangam (India) Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 50.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 50.00 Cr..
• For Reserves, as of Mar 2025, the value is 957.00 Cr.. The value appears strong and on an upward trend. It has increased from 934.00 Cr. (Mar 2024) to 957.00 Cr., marking an increase of 23.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1,138.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 1,066.00 Cr. (Mar 2024) to 1,138.00 Cr., marking an increase of 72.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 811.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 679.00 Cr. (Mar 2024) to 811.00 Cr., marking an increase of 132.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,955.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,729.00 Cr. (Mar 2024) to 2,955.00 Cr., marking an increase of 226.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,278.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,007.00 Cr. (Mar 2024) to 1,278.00 Cr., marking an increase of 271.00 Cr..
• For CWIP, as of Mar 2025, the value is 179.00 Cr.. The value appears to be declining and may need further review. It has decreased from 221.00 Cr. (Mar 2024) to 179.00 Cr., marking a decrease of 42.00 Cr..
• For Investments, as of Mar 2025, the value is 80.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Mar 2024) to 80.00 Cr., marking an increase of 69.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,419.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,489.00 Cr. (Mar 2024) to 1,419.00 Cr., marking a decrease of 70.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,955.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,729.00 Cr. (Mar 2024) to 2,955.00 Cr., marking an increase of 226.00 Cr..

However, the Borrowings (1,138.00 Cr.) are higher than the Reserves (957.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Sangam (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 6.33. This value is within the healthy range. It has decreased from 8.21 (Mar 24) to 6.33, marking a decrease of 1.88.
• For Diluted EPS (Rs.), as of Mar 25, the value is 6.33. This value is within the healthy range. It has decreased from 8.21 (Mar 24) to 6.33, marking a decrease of 1.88.
• For Cash EPS (Rs.), as of Mar 25, the value is 29.11. This value is within the healthy range. It has increased from 27.39 (Mar 24) to 29.11, marking an increase of 1.72.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 200.35. It has increased from 195.88 (Mar 24) to 200.35, marking an increase of 4.47.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 200.35. It has increased from 195.88 (Mar 24) to 200.35, marking an increase of 4.47.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 568.55. It has increased from 523.00 (Mar 24) to 568.55, marking an increase of 45.55.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 51.74. This value is within the healthy range. It has increased from 45.43 (Mar 24) to 51.74, marking an increase of 6.31.
• For PBIT / Share (Rs.), as of Mar 25, the value is 28.96. This value is within the healthy range. It has increased from 26.16 (Mar 24) to 28.96, marking an increase of 2.80.
• For PBT / Share (Rs.), as of Mar 25, the value is 8.80. This value is within the healthy range. It has decreased from 10.62 (Mar 24) to 8.80, marking a decrease of 1.82.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 6.33. This value is within the healthy range. It has decreased from 8.12 (Mar 24) to 6.33, marking a decrease of 1.79.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 6.33. This value is within the healthy range. It has decreased from 8.12 (Mar 24) to 6.33, marking a decrease of 1.79.
• For PBDIT Margin (%), as of Mar 25, the value is 9.10. This value is below the healthy minimum of 10. It has increased from 8.68 (Mar 24) to 9.10, marking an increase of 0.42.
• For PBIT Margin (%), as of Mar 25, the value is 5.09. This value is below the healthy minimum of 10. It has increased from 5.00 (Mar 24) to 5.09, marking an increase of 0.09.
• For PBT Margin (%), as of Mar 25, the value is 1.54. This value is below the healthy minimum of 10. It has decreased from 2.03 (Mar 24) to 1.54, marking a decrease of 0.49.
• For Net Profit Margin (%), as of Mar 25, the value is 1.11. This value is below the healthy minimum of 5. It has decreased from 1.55 (Mar 24) to 1.11, marking a decrease of 0.44.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.11. This value is below the healthy minimum of 8. It has decreased from 1.55 (Mar 24) to 1.11, marking a decrease of 0.44.
• For Return on Networth / Equity (%), as of Mar 25, the value is 3.15. This value is below the healthy minimum of 15. It has decreased from 4.14 (Mar 24) to 3.15, marking a decrease of 0.99.
• For Return on Capital Employeed (%), as of Mar 25, the value is 8.10. This value is below the healthy minimum of 10. It has increased from 7.92 (Mar 24) to 8.10, marking an increase of 0.18.
• For Return On Assets (%), as of Mar 25, the value is 1.07. This value is below the healthy minimum of 5. It has decreased from 1.49 (Mar 24) to 1.07, marking a decrease of 0.42.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.71. This value is within the healthy range. It has increased from 0.62 (Mar 24) to 0.71, marking an increase of 0.09.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.13. This value exceeds the healthy maximum of 1. It has increased from 1.08 (Mar 24) to 1.13, marking an increase of 0.05.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.01. It has decreased from 1.07 (Mar 24) to 1.01, marking a decrease of 0.06.
• For Current Ratio (X), as of Mar 25, the value is 1.20. This value is below the healthy minimum of 1.5. It has decreased from 1.27 (Mar 24) to 1.20, marking a decrease of 0.07.
• For Quick Ratio (X), as of Mar 25, the value is 0.69. This value is below the healthy minimum of 1. It has increased from 0.64 (Mar 24) to 0.69, marking an increase of 0.05.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.59. This value is within the healthy range. It has increased from 3.11 (Mar 24) to 4.59, marking an increase of 1.48.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 31.60. This value is within the healthy range. It has increased from 24.62 (Mar 24) to 31.60, marking an increase of 6.98.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 6.86. This value is below the healthy minimum of 20. It has decreased from 7.30 (Mar 24) to 6.86, marking a decrease of 0.44.
• For Earning Retention Ratio (%), as of Mar 25, the value is 68.40. This value is within the healthy range. It has decreased from 75.38 (Mar 24) to 68.40, marking a decrease of 6.98.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 93.14. This value exceeds the healthy maximum of 70. It has increased from 92.70 (Mar 24) to 93.14, marking an increase of 0.44.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.75. This value is below the healthy minimum of 3. It has decreased from 3.20 (Mar 24) to 2.75, marking a decrease of 0.45.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.41. This value is below the healthy minimum of 3. It has decreased from 1.66 (Mar 24) to 1.41, marking a decrease of 0.25.
• For Enterprise Value (Cr.), as of Mar 25, the value is 3,276.15. It has increased from 3,240.46 (Mar 24) to 3,276.15, marking an increase of 35.69.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.15. This value is within the healthy range. It has decreased from 1.23 (Mar 24) to 1.15, marking a decrease of 0.08.
• For EV / EBITDA (X), as of Mar 25, the value is 12.60. This value is within the healthy range. It has decreased from 14.20 (Mar 24) to 12.60, marking a decrease of 1.60.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.76. This value is below the healthy minimum of 1. It has decreased from 0.83 (Mar 24) to 0.76, marking a decrease of 0.07.
• For Retention Ratios (%), as of Mar 25, the value is 68.39. This value is within the healthy range. It has decreased from 75.37 (Mar 24) to 68.39, marking a decrease of 6.98.
• For Price / BV (X), as of Mar 25, the value is 2.18. This value is within the healthy range. It has decreased from 2.24 (Mar 24) to 2.18, marking a decrease of 0.06.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.76. This value is below the healthy minimum of 1. It has decreased from 0.83 (Mar 24) to 0.76, marking a decrease of 0.07.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness